SCANCELL HOLDINGS PLC ORD 0.1P吧
排序：
评论时间
  • 评论时间
  • 发帖时间
阅读评论标题 作者 最后更新
22 0 公告 Director Dealing SCANCELL HOLDING资讯 08-08 19:33
21 0 公告 Director/PDMR Shareholding SCANCELL HOLDING资讯 08-04 17:26
22 0 公告 Strong Phase 2 data on iSCIB1+ in Melanoma SCANCELL HOLDING资讯 07-22 14:23
27 0 公告 Share Option Exercise SCANCELL HOLDING资讯 07-16 14:22
20 0 公告 Scancell initiates new arm in SCOPE Phase 2 study SCANCELL HOLDING资讯 06-25 14:15
26 0 公告 Director Dealing SCANCELL HOLDING资讯 05-21 14:21
35 0 公告 Partnership with NHS Cancer Vaccine Launch Pad SCANCELL HOLDING资讯 04-14 14:14
31 0 公告 Scancell to present at 2025 AACR Annual Meeting SCANCELL HOLDING资讯 04-01 15:09
33 0 公告 Issue of share options SCANCELL HOLDING资讯 02-20 15:23
37 0 公告 Scancell presenting at AACR IO conference SCANCELL HOLDING资讯 02-17 15:11
50 0 公告 Interim Results SCANCELL HOLDING资讯 01-30 15:15
32 0 公告 Notice of Interim Results SCANCELL HOLDING资讯 01-23 15:12
41 0 公告 Modi-1 Vaccine Achieves Early Clinical Validation SCANCELL HOLDING资讯 01-09 15:16
62 0 公告 Result of Retail Offer and Total Voting Rights SCANCELL HOLDING资讯 12-09 19:44
63 0 公告 Result of Placing and Subscription SCANCELL HOLDING资讯 12-05 20:43
66 0 公告 Retail Offer for up to ￡1 million SCANCELL HOLDING资讯 12-05 02:06
63 0 公告 Proposed fundraise in excess of ￡8.5 million SCANCELL HOLDING资讯 12-05 02:04
56 0 公告 Second Commercial License Agreement with Genmab SCANCELL HOLDING资讯 12-04 15:16
50 0 公告 Positive data from Phase 2 SCOPE trial with SCIB1 SCANCELL HOLDING资讯 11-18 15:16
66 0 公告 Result of Annual General Meeting SCANCELL HOLDING资讯 10-25 22:31
66 0 公告 Holding(s) in Company SCANCELL HOLDING资讯 10-24 14:19
66 0 公告 Scancell Appoints Dr Phil L’Huillier as CEO SCANCELL HOLDING资讯 10-22 14:15
58 0 公告 Notice of AGM SCANCELL HOLDING资讯 10-01 14:21
59 0 公告 Results Year Ended 30 April 2024 SCANCELL HOLDING资讯 09-24 14:40
66 0 公告 Notice of Final Results SCANCELL HOLDING资讯 09-18 14:19
59 0 公告 Strategic Partnership with PharmaJet SCANCELL HOLDING资讯 09-17 14:15
49 0 公告 Scancell to attend upcoming conferences SCANCELL HOLDING资讯 09-02 14:16
54 0 公告 Scancell Appoints Dr Nermeen Varawalla as CMO SCANCELL HOLDING资讯 07-30 15:22
60 0 公告 Update from iSCIB1+ Clinical Advisory Meeting SCANCELL HOLDING资讯 07-24 15:08
62 0 公告 Appointment of Dr Florian Reinaud to the Board SCANCELL HOLDING资讯 07-10 15:09
65 0 公告 Extension of Convertible Loan Notes SCANCELL HOLDING资讯 07-02 15:08
58 0 公告 Block Listing Return and Total Voting Rights SCANCELL HOLDING资讯 07-01 17:58
68 0 公告 Change of Nominated Advisor SCANCELL HOLDING资讯 06-21 15:19
73 0 公告 Agreement with major biotech SCANCELL HOLDING资讯 06-12 15:37
55 0 公告 Scancell to attend upcoming conferences SCANCELL HOLDING资讯 05-31 15:08
54 0 公告 Update on ModiFY trial SCANCELL HOLDING资讯 05-30 15:09
54 0 公告 Scancell to present at ASCO Annual Meeting SCANCELL HOLDING资讯 05-24 15:08
50 0 公告 Issue of share options SCANCELL HOLDING资讯 05-21 15:07
60 0 公告 Presenting at the Sachs 10th Annual Oncology Forum SCANCELL HOLDING资讯 05-16 15:08
56 0 公告 Scancell presenting at 21st CIMT Annual Meeting SCANCELL HOLDING资讯 05-09 15:08
57 0 公告 Presenting at the Annual Immuno-Oncology Summit SCANCELL HOLDING资讯 04-17 15:07
49 0 公告 Block Listing Six Monthly Return SCANCELL HOLDING资讯 04-16 15:07
48 0 公告 Employee exercise of share options SCANCELL HOLDING资讯 04-03 15:08
75 0 公告 Scancell to Present at 2024 AACR Annual Meeting SCANCELL HOLDING资讯 04-02 15:10
57 0 公告 Scancell Appoints WG as Joint Broker SCANCELL HOLDING资讯 03-28 22:28
46 0 公告 First iSCIB1+ patient dosed SCANCELL HOLDING资讯 03-26 21:27
54 0 公告 Appointment of Sath Nirmalananthan to the Board SCANCELL HOLDING资讯 03-14 20:23
52 0 公告 Scancell Attendance at Upcoming Conferences SCANCELL HOLDING资讯 03-12 16:08
70 0 公告 Presenting at Next-Gen Immuno-Oncology Conference SCANCELL HOLDING资讯 03-04 16:07
69 0 公告 Change of Auditor SCANCELL HOLDING资讯 02-20 16:09
89 0 公告 Directorate Change SCANCELL HOLDING资讯 02-05 17:25
63 0 公告 Interim Results SCANCELL HOLDING资讯 01-30 16:22
111 0 公告 Notice of Interim Results and Presentation SCANCELL HOLDING资讯 01-26 00:00
74 0 公告 Update on SCOPE trial SCANCELL HOLDING资讯 01-17 22:52
72 0 公告 Holding(s) in Company SCANCELL HOLDING资讯 12-29 02:43
72 0 公告 Holding(s) in Company SCANCELL HOLDING资讯 12-27 20:43
83 0 公告 Result of the Open Offer SCANCELL HOLDING资讯 12-19 16:08
78 0 公告 PDMR Notification SCANCELL HOLDING资讯 12-06 21:48
77 0 公告 Results of Placing SCANCELL HOLDING资讯 12-01 16:10
68 0 公告 Proposed Capital Raise to raise approximately ￡6m SCANCELL HOLDING资讯 12-01 02:07
88 0 公告 Result of AGM SCANCELL HOLDING资讯 11-29 23:43
72 0 公告 Update on SCOPE trial SCANCELL HOLDING资讯 11-28 16:09
65 0 公告 Scancell to present at 20th SMR Congress SCANCELL HOLDING资讯 11-10 17:43
70 0 公告 Scancell to present at 38th Annual SITC meeting SCANCELL HOLDING资讯 11-01 16:10
83 0 公告 Notice of AGM SCANCELL HOLDING资讯 10-31 21:03
64 0 公告 Results for the Year Ended 30 April 2023 SCANCELL HOLDING资讯 10-31 16:11
79 0 公告 Update on Final Results SCANCELL HOLDING资讯 10-20 15:10
80 0 公告 Scancell to speak at World Vaccine Congress Europe SCANCELL HOLDING资讯 10-18 15:09
77 0 公告 Block Listing Six Monthly Return SCANCELL HOLDING资讯 10-17 15:12
84 0 公告 Change of Date for Final Results SCANCELL HOLDING资讯 10-11 15:10
83 0 公告 Notice of Final Results and Investor Presentation SCANCELL HOLDING资讯 10-03 15:11
92 0 公告 Positive data from Phase 2 SCOPE trial with SCIB1 SCANCELL HOLDING资讯 09-19 15:11
76 0 公告 Scancell to present three posters at ICI SCANCELL HOLDING资讯 09-14 15:19
86 0 公告 Scancell Appoints Head of Business Development SCANCELL HOLDING资讯 09-07 15:03
80 0 公告 Scancell Appoints Sath Nirmalananthan as CFO SCANCELL HOLDING资讯 08-29 15:13
78 0 公告 Modi-1 trial open for expansion in CPI combination SCANCELL HOLDING资讯 07-31 15:06
76 0 公告 Extension of exercise period for CEO share options SCANCELL HOLDING资讯 07-13 17:25
85 0 公告 Pipeline strategy and business update SCANCELL HOLDING资讯 07-10 15:05
149 0 公告 Scancell to Present Modi-1 Data at ASCO SCANCELL HOLDING资讯 06-02 15:10
107 0 公告 Issue of share options to Non-Executive Directors SCANCELL HOLDING资讯 04-21 15:17
发表新主题
悬赏提问
帖子不见了！怎么办？   
   请登录 登录 | 5秒注册 作者： 退出 
温馨提示： 1.根据《证券法》规定，禁止编造、传播虚假信息或者误导性信息，扰乱证券市场；2.用户在本社区发表的所有资料、言论等仅代表个人观点，与本网站立场无关，不对您构成任何投资建议。用户应基于自己的独立判断，自行决定证券投资并承担相应风险。《东方财富社区管理规定》
东方财富

扫一扫下载APP
东方财富产品
证券交易
关注东方财富
天天基金

扫一扫下载APP
基金交易
关注天天基金
东方财富期货

扫一扫下载APP
期货交易
信息网络传播视听节目许可证：0908328号 经营证券期货业务许可证编号：913101046312860336 违法和不良信息举报:021-34289898 举报邮箱：jubao@eastmoney.com
沪ICP证:沪B2-20070217 网站备案号:沪ICP备05006054号-11 沪公网安备 31010402000120号 版权所有:东方财富网 意见与建议:021-54509966/952500
关于我们 广告服务 联系我们 诚聘英才 免责声明 法律声明 隐私保护 征稿启事 放心搜 友情链接